BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2989880)

  • 1. Role of the immune system in bluetongue host-viral interactions.
    Osburn BI
    Prog Clin Biol Res; 1985; 178():417-22. PubMed ID: 2989880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune response of sheep to bluetongue virus.
    Ghalib HW; Cherrington JM; Adkison MA; Osburn BI
    Prog Clin Biol Res; 1985; 178():489-96. PubMed ID: 2989890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bluetongue: a review of the immune response of sheep and cattle to bluetongue virus infection.
    Jochim MM
    Prog Clin Biol Res; 1985; 178():455-60. PubMed ID: 2989885
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of recombinant bluetongue virus antigens, using dot immunobinding assay with serum from sheep and cattle.
    Naresh A; Roy P; Prasad G
    Am J Vet Res; 1996 Nov; 57(11):1556-8. PubMed ID: 8915428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of ovine cytotoxic T cells in protection against bluetongue virus infection.
    Jeggo MH; Wardley RC; Brownlie J
    Prog Clin Biol Res; 1985; 178():477-87. PubMed ID: 2989889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral responses of bluetongue virus-inoculated bovine fetuses and their dams.
    MacLachlan NJ; Schore CE; Osburn BI
    Am J Vet Res; 1984 Jul; 45(7):1469-73. PubMed ID: 24049920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response of calves to bluetongue virus infection.
    MacLachlan NJ; Heidner HW; Fuller FJ
    Am J Vet Res; 1987 Jul; 48(7):1031-5. PubMed ID: 2820272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bluetongue in cattle: effects of vector-transmitted bluetongue virus on calves previously infected in utero.
    Luedke AJ; Jochim MM; Jones RH
    Am J Vet Res; 1977 Nov; 38(11):1697-1700. PubMed ID: 201193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of serology in bluetongue epidemiology.
    Taylor WP; Gumm ID; Gibbs EP; Homan J
    Prog Clin Biol Res; 1985; 178():461-8. PubMed ID: 2989886
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep.
    Umeshappa CS; Singh KP; Pandey AB; Singh RP; Nanjundappa RH
    Vaccine; 2010 Mar; 28(13):2522-31. PubMed ID: 20117268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A seroepidemiologic survey of antibody to bluetongue virus in Alabama cattle.
    Haynes TB; Harrold S; Schultz RD
    Cornell Vet; 1982 Jul; 72(3):262-8. PubMed ID: 6286249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ovine cytotoxic T lymphocyte responses to bluetongue virus.
    Janardhana V; Andrew ME; Lobato ZI; Coupar BE
    Res Vet Sci; 1999 Dec; 67(3):213-21. PubMed ID: 10607500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cell-mediated immunity in the pathogenesis of bluetongue virus serotype 11 in the experimental infection of vaccine/sensitized calves.
    Odeón AC; Schore CE; Osburn BI
    Comp Immunol Microbiol Infect Dis; 1997 Jun; 20(3):219-31. PubMed ID: 9280389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle.
    Wäckerlin R; Eschbaumer M; König P; Hoffmann B; Beer M
    Vaccine; 2010 Jun; 28(27):4348-55. PubMed ID: 20438878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two alternative inocula to reproduce bluetongue virus serotype 8 disease in calves.
    Martinelle L; Dal Pozzo F; Sarradin P; De Leeuw I; De Clercq K; Thys C; Ziant D; Thiry E; Saegerman C
    Vaccine; 2011 Apr; 29(19):3600-9. PubMed ID: 21376798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bluetongue virus in cattle: complement fixing antibody response and viremia in experimentally infected animals.
    Pearson JE; Carbrey EA; Gustafson GA
    Proc Annu Meet U S Anim Health Assoc; 1973; (77):524-31. PubMed ID: 4377944
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiologic implications of the genetic variations of bluetongue virus.
    Barber TL; Collisson EW
    Prog Clin Biol Res; 1985; 178():597-606. PubMed ID: 2989909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque neutralization cross reactivity of post infection bovine sera amongst bluetongue virus serotypes.
    Thomas FC
    Prog Clin Biol Res; 1985; 178():511-2. PubMed ID: 2989894
    [No Abstract]   [Full Text] [Related]  

  • 20. Subclinical and clinical bluetongue disease in cattle: clinical, pathological and pathogenic considerations.
    Anderson GA; Stott JL; Gershwin LJ; Osburn BI
    Prog Clin Biol Res; 1985; 178():103-7. PubMed ID: 2989843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.